Iambic Therapeutics

IAM
13.10011.73% ( -1.740 )
Closed: Nov 13, 16:00:00 (EDT)

Profile

About

Iambic Therapeutics
Iambic Therapeutics
IAM.US

Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc.

Profile

Company Name
Iambic Therapeutics, Inc.
Market
NasdaqGS
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management